Patent ID: 7189702

Claim:
A glucopyranosyloxypyrazole derivative represented by the general formula: wherein one of Q and T represents a group represented by the general formula: wherein P represents a hydrogen atom or a group forming prodrug; the other represents a lower alkyl group or a halo (lower alkyl) group; R 11 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a cyclic lower alkyl group, a cyclic lower alkyl-substituted (lower alkyl) group, a group forming prodrug or a group represented by the general formula: P 1 -O-A 1 - wherein P 1 represents a hydrogen atom or a group forming prodrug; and A 1 represents a lower alkylene group; R 12 represents a lower alkenyl group, a cyclic lower alkyl group, a cyclic lower alkoxy group, a cyclic lower alkylidenemethyl group, a phenyl group which may have 1–3 different or same groups selected from a halogen atom and a hydroxy group, a 5- or 6-membered aromatic heterocyclic group which contains 1–4 different or same atoms selected from an oxygen atom, a sulfur atom and a nitrogen atom in the ring, or a group represented by the general formula: P 2 -O-A 2 - wherein P 2 represents a hydrogen atom or a group forming prodrug; and A 2 represents a lower alkylene group; and with the proviso that at least one of P, R 11 and R 12 has a group forming prodrug, or a pharmaceutically acceptable salt thereof.